Comment on "Is Group Testing Ready for Prime Time in Disease Identification?"
- PMID: 34251035
- DOI: 10.1002/sim.9078
Comment on "Is Group Testing Ready for Prime Time in Disease Identification?"
Comment in
-
Rejoinder to discussion on Is group testing ready for prime-time in disease identification?Stat Med. 2021 Jul 30;40(17):3892-3894. doi: 10.1002/sim.9033. Stat Med. 2021. PMID: 34251036 Free PMC article. No abstract available.
Comment on
-
Is group testing ready for prime-time in disease identification?Stat Med. 2021 Jul 30;40(17):3865-3880. doi: 10.1002/sim.9003. Epub 2021 Apr 28. Stat Med. 2021. PMID: 33913183 Free PMC article.
References
REFERENCES
-
- Rogan WJ, Gladen B. Estimating prevalance from the results of a screening test. Am J Epidemiol. 1978;107:71-76.
-
- Gastwirth JL, Johnson WO, Reneau DM. Bayesian analysis of screening data: application to AIDS in blood donors. Can J Stat. 1991;19:135-150.
-
- Johnson W, Gastwirth J. Bayesian inference for medical screening tests: Approximations useful for the analysis of acquired immune deficiency syndrome. Journal of the Royal Statistical Society, Series B. 1991;53:427-439.
-
- Johnson WO, Gastwirth JL, Pearson LM. Screening without a gold standard: the Hui-Walter paradigm revisited. Am J Epidemiol. 2001;153:921-924.
-
- Hui S, Walter S. Estimating the error rates of diagnostic tests. Biometrics. 1980;36:167-171.